Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk Factors Related to Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis in High-risk Patients Who Underwent ERCP and Received Prophylactic Rectal Indomethacin

NCT02709421 is registered in ClinicalTrials.gov with Air Force Military Medical University, China as lead sponsor.

NCT NCT02709421
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02709421 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk Factors Related to Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis in High-risk Patients Who Underwent ERCP and Received Prophylactic Rectal Indomethacin
Lead sponsor
Air Force Military Medical University, China
Phase
Observational
Overall status
Completed
Start date
February 29, 2016
Completion date
September 30, 2016
Enrollment
790 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

healthy